Health Canada’s Dealer’s Licence & Section 56 Explained with Benjamin Lightburn

Filament Health produces non-synthetic psychedelic substances for research and treatment. They’re known as the first lab to have non-synthesized psilocybin for clinical trials and hope to show the efficacy of naturally derived psychedelics. Benjamin explains some current clinical trials as they test out the difference between oral and sublingual administration of psilocybin.We also dive into the Special Access Program and how to apply to Health Canada for access to non-approved drugs for experimental treatments of depression.You can keep in touch with Benjamin on Twitter (@benlightburn) or with Filament Health on Twitter (@FilamentHealth), Instagram (@FilamentHealth), or on their website (filament.health)